SEC Form 4 · accession 0001127602-18-008326

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Corporate Executive VP

Period of report

Feb 23, 2018

Accepted (ET)

Feb 26, 2018 · 2:01 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001100682

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock^F1	Feb 23, 2018	A	947	$0.00	A	193,905	D
Common Stock^F2	Feb 23, 2018	A	5,869	$0.00	A	199,774	D
Common Stock	Feb 24, 2018	F	981	$109.34	D	198,793	D
Common Stock	Feb 26, 2018	F	1,033	$109.34	D	197,760	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Options (Right to Buy)^F3	$109.34	Feb 23, 2018	A	26,491	A	Feb 23, 2019	Feb 23, 2023	Common Stock	26,491	26,491	D

F1Consists of 947 unvested restricted stock units that vest as follows: 473 shares vest one (1) year from the date of grant, and 474 shares vest two (2) years from the date of grant.
F2Consists of 5,869 unvested restricted stock units that vest as follows: 1,467 shares vest one (1) year from the date of issuance, 1,467 shares vest two (2) years from the date of issuance, 1,467 shares vest three (3) years from the date of issuance, and 1,468 shares vest four (4) years from the date of issuance.
F3Stock options vest as follows: 6,622 options vest one (1) year from the date of grant, 6,623 options vest two (2) years from the date of grant, 6,623 options vest three (3) years from the date of grant, and 6,623 options vest four (4) years from the date of grant.